#type 2 diabetes

#type 2 diabetes

The emergence of type 2 diabetes in youth, once solely an adult disease, is linked to factors like obesity, lifestyle, environment, and disparities in access to healthy resources.

Higher muscle strength significantly reduces the risk of type 2 diabetes, regardless of one's genetic susceptibility.

Demand for Ozempic and its alternatives has led to compounded versions, but brand manufacturers are actively trying to eliminate this competition.

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.

Lilly's shares surged 15% following promising clinical trial results for orforglipron.

Orforglipron pill shows effectiveness similar to injectable GLP-1s for diabetes and weight loss.